I

Incyte

2500 employees

Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.

Investor insights

Sectors invested in

Therapeutics2
Medical2
Biotechnology2
Immunotherapy1
Health Care1
Medical Device1
Inflammatory Disorders1
Targeted Protein Degredation1
Small Molecules1
Cancer1
Biotech1
Antibodies1
Cell therapy1
GMP Manufacturing1
Checkpoint Inhibitors and Modulators1
Immuno-oncology1
Cancer Vaccines1

Funding rounds participated in

$20M sweet spot round size

Most of their 5 investments are in rounds between $2M and $24M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Medical Device
Biotechnology
Immunology
Health Care
Oncology
Medical
Inflammation
Pharmaceutical
Targeted Therapy
Immuno-oncology

Date founded

1991

Investments made

B

BioTheryX, Inc. raised $6M on April 5, 2023

Investors: Incyte

A

Agenus raised $60M on February 14, 2017

Investors: Incyte

U

Undisclosed raised $20M on March 27, 2002

Investors: Abingworth and Incyte

U

Undisclosed raised $24M on July 26, 2001

Investors: MVM Partners and Incyte

U

Undisclosed raised $2M on June 26, 2000

Investors: Wilson Sonsini Goodrich & Rosati and Incyte

FAQ